MEDFORD, Massachusetts, March 7 -- Cancer Medicine, a peer-reviewed journal that says it features research from biomedical researchers across the cancer sciences, published research articles on the following topics in its Vol. 12, No. 3 edition:

REVIEWS:

* Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data

* Different predictive values of microvessel density f . . .

Click here for more information about our products